Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000246306 | SCV000319021 | likely benign | Cardiovascular phenotype | 2013-11-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000424783 | SCV000530464 | likely benign | not specified | 2016-07-27 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000476736 | SCV000542256 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-05-17 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000725903 | SCV000701186 | uncertain significance | not provided | 2017-05-19 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000725903 | SCV004150302 | likely benign | not provided | 2022-09-01 | criteria provided, single submitter | clinical testing | TTN: BP4, BP7 |